Pharmacokinetic assessment of irinotecan, SN-38, and SN-38-glucuronide: A substudy of the FIRIS study

导出原文传递

翻译打印收藏纠错

作者： Satoh,T. ^[1] ; Yasui,H. ^[2] ; Muro,K. ^[3] ; Komatsu,Y. ^[4] ; Sameshima,S. ^[5] ; Yamaguchi,K. ^[6] ; Sugihara,K. ^[7]

作者单位： Shizuoka Cancer Center, Shizuoka, Japan ^[1] Aichi Cancer Center Hospital, Nagoya, Japan ^[2] Saitama Cancer Center, Saitama, Japan ^[3] Department of Frontier Science for Cancer and Chemotherapy, Osaka University Graduate School of ^[4] Hokkaido University Hospital Cancer Center, Sapporo, Japan ^[5] Dokkyo Medical University Koshigaya Hospital, Saitama, Japan ^[6] Tokyo Medical and Dental University, Tokyo, Japan ^[7]

关键词 Colorectal cancer FIRIS Irinotecan IRIS S-1

发布时间 2014-01-21

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Anticancer Research

2013年33卷9期

3845-3854页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Pharmacokinetic assessment of irinotecan, SN-38, and SN-38-glucuronide: A substudy of the FIRIS study

Anticancer Research

相似文献

Anticancer Research

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Pharmacokinetic assessment of irinotecan, SN-38, and SN-38-glucuronide: A substudy of the FIRIS study

Anticancer Research

相似文献

Anticancer Research

相关期刊

检索历史清除